Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid drag

May 4, 2026

Indian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lost Revlimid sales and pricing challenges. Lupin and Divi’s are poised for strong performance, with Sun Pharma and Torrent showing resilience. Apollo Hospitals expects robust traction across its diverse segments.

More To Explore

South Korea stocks plunge 8%, circuit breaker triggered as chip shares tumble

South Korea’s KOSPI stock index fell more than 8% during early trading on Friday, reflecting a significant sell-off. The stock market decline was primarily driven

November 6, 2026

Gold price prediction: Will gold continue its surge on Dhanteras? Check outlook for November 6

In today’s session, Spot gold rose 0.4% to $4,103.55 per ounce, taking its weekly gains to 5.9%. US gold futures for December delivery were little

November 6, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003